pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-3123 |
Genomic Coordinates | chr1: 241132272 - 241132346 |
Description | Homo sapiens miR-3123 stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Mature miRNA Information | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-3123 | ||||||||||||||
Sequence | 49| CAGAGAAUUGUUUAAUC |65 | ||||||||||||||
Evidence | Experimental | ||||||||||||||
Experiments | Illumina | ||||||||||||||
Editing Events in miRNAs |
|
||||||||||||||
SNPs in miRNA |
|
||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | IFNAR1 | ||||||||||||||||||||
Synonyms | AVP, IFN-alpha-REC, IFNAR, IFNBR, IFRC | ||||||||||||||||||||
Description | interferon alpha and beta receptor subunit 1 | ||||||||||||||||||||
Transcript | NM_000629 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on IFNAR1 | |||||||||||||||||||||
3'UTR of IFNAR1 (miRNA target sites are highlighted) |
>IFNAR1|NM_000629|3'UTR 1 CCAGAAATGAACTGTGTCAAGTATAAGGTTTTTCAGCAGGAGTTACACTGGGAGCCTGAGGTCCTCACCTTCCTCTCAGT 81 AACTACAGAGAGGACGTTTCCCTGTTTAGGGAAAGAAAAAACATCTTCAGATCATAGGTCCTAAAAATACGGGCAAGCTC 161 TTAACTATTTAAAAATGAAATTACAGGCCCGGGCACGGTGGCTCACACCTGTAATCCCAGCACTTTGGGAGGCTGAGGCA 241 GGCAGATCATGAGGTCAAGAGATCGAGACCAGCCTGGCCAACGTGGTGAAACCCCATCTCTACTAAAAATACAAAAATTA 321 GCCGGGTGTGGTGGCGCGCGCCTGTTGTCTTAGCTACTCAGGAGGCTGAGGCAGGAGAATCGCTTGAAAACAGGAGGTGG 401 AGGTTGCAGTGAGCCGAGATCACGCCACTGCACTCCAGCCTGGTGACAGCGTGAGACTCTTTAAAAAAAGAAATTAAAAG 481 AGTTGAGACAAACGTTTCCTACATTCTTTTCCATGTGTAAAATCATGAAAAAGCCTGTCACCGGACTTGCATTGGATGAG 561 ATGAGTCAGACCAAAACAGTGGCCACCCGTCTTCCTCCTGTGAGCCTAAGTGCAGCCGTGCTAGCTGCGCACCGTGGCTA 641 AGGATGACGTCTGTGTTCCTGTCCATCACTGATGCTGCTGGCTACTGCATGTGCCACACCTGTCTGTTCGCCATTCCTAA 721 CATTCTGTTTCATTCTTCCTCGGGAGATATTTCAAACATTTGGTCTTTTCTTTTAACACTGAGGGTAGGCCCTTAGGAAA 801 TTTATTTAGGAAAGTCTGAACACGTTATCACTTGGTTTTCTGGAAAGTAGCTTACCCTAGAAAACAGCTGCAAATGCCAG 881 AAAGATGATCCCTAAAAATGTTGAGGGACTTCTGTTCATTCATCCCGAGAACATTGGCTTCCACATCACAGTATCTACCC 961 TTACATGGTTTAGGATTAAAGCCAGGCAATCTTTTACTATGCATTAAGACCTCTGATTCAAAACTTATTAGAACAGTAGC 1041 TTCTGCTGGAATTTGCAATCACTGAAGTCATAGAAAATAGGTAACTATCTAATTAGAGAAATAATTGTTGTATTTTAAGA 1121 TCTGAGAGTGTGTACAAGTTTTAGTATACATGCCATGCCAGAAGATAGTGTATGCAAGAAGTCTTGGGACCAGAAAATGG 1201 CAATGATAGGAGACTGACATAGAAGAAGAATGCTTCCCTAGGAAAAAGGTCGCTGGCTTTGGTGCAAGAGGAAGAAGAAT 1281 GTTCCACTGGAAGCCTGAGCACCTAATCAGCTCTCAGTGATCAACCCACTCTTGTTATGGGTGGTCTCTGTCACTTTGAA 1361 TGCCAGGCTGGCTTCTCGTCTAGCAGTATTCAGATACCCCTTCTGCTCAGCCTGCTTGGCGTTAAAATACAAATCATTGA 1441 ACTGAGGGGGAAAAATGTAACTAGGAAGAAAAACCCAATTTAAGAAATTACATAATGCTTTCCAAAGGCACCTACAACTT 1521 AGTTTTAAATTACTTGCTACTGGGGATTACCCATGGATATCCTTAATAGGCAGGAAGTCTGGGAATTCTGGTGGCCTCTA 1601 GGGCAGTGTTCTCACAGCACCGTTCCGACAGGGACCAGTGAAAGAAAAGAGACAAAGTTAGAACGTGCTGGGGAGCGGCC 1681 ATTTCTAAGGCCAGTCTGGTTTAAGTAGTCATTTCTGCTGAAAAAACAGATGATCCTGGTGGAAGAAAAGGTTGAAGGCA 1761 GCTGCCCTCGGGAGGGCTGTGATGCTCGGCACATCCTGCCTGGCACATACACGTGTCTGCAGGCCACACCGTGCATGTCC 1841 CCAGACCTGCCGCCTGGCTTCTGGAGTGCTTCAAGCAGAGCATGGTGGGTCATTGAGGAGACCCAGGAATCTCATCTGAG 1921 AACCCACTCTCTGCCGGAGAACCCCATGGTGACACATTTTCATCTTTCTGACCAGAGGCTGTTTTTTTTTTTTTTTGAGA 2001 CAGTCTCATTCTGTTGCCCAGGCTGGAGTGCAGTGGCTTGATCTCGGCTCACTGCAACCTCGCCTCCCGGGTTCAAGCAA 2081 TTCTCTGCCGCAGCCTCCAGAGTAGCTGGGATAACAGGTGCCCACCACCACACCCCACTAATTTTTGTATTTGTATTTTT 2161 AGTAGAGATGGGGTTTCACCATGTTGGTCAGGCTGGTCTTGGACTCCTGACCTCATGCTCCACCCGCTTCGGCCTCCCAA 2241 AGTTCTGGGATTACAGGTGTGAGCCACCGTGCACGGCCGGCCTGACCTTTGGAAAAGCCTTGTCACTTTGGACGTTTGCG 2321 TCTTTGAAGAGGCGATGGGAGCATATCATGACTGCCTGCCACCATTGCTTTTCAGACTACCACAACTCAATCATGCTGTC 2401 CAGGACTTCTGGCCCTGTGTTCACCACTGGGAAAACGTACTTCAGACTGGATAGCCTAAAAAGGAGCAATGCCCTTGTAG 2481 GATGTGGAGAAGGGAAAATACGGACATTAACATTAAAAGACACCAGTGAAATTGTTAGGTCTCTAGGAAGTTGGAGCACA 2561 AGGCTTCACGCTTTAAGACCATCTGTGGTTTTCAGTGAACAAGCGCTGAGCACCAGCAGCAGAAAACAACAACAAAAAAA 2641 CACCTCGTTTTTACCTTGTCTTCTAGACATGAAAAGGCAGTTGCATTCCACTCTGCATTATGTTCTACATGTTGCTTTAT 2721 CAGTATATGCTTAGCTGTAAGTGACAAGTATTTTTTCTGAACAGAAGTTTACTTAGAAATACCATGCACTTGGGGGTACC 2801 AATTAACCGCCTGAAAATTAGCATATTGATAGTTCTTAGAGAGACCAGATATAATCTAAGAATTTATATGAAAGATTTGT 2881 ATCATTAGAGCCAGAAATAATTTTATATTAATATATAATACAGATTAACATTATATATAATATGTACCTGTGTCACTTCT 2961 GACATGAGCCTGTAAACATATATTCATATATGTACCTGCACATGTACCCACCTGATGTAGGTCTTATTCCTTTAGTATGG 3041 ACTTAAAGTACTTATTCATATACCTTGTAACTAAAAATTAGAACAGCTCCCTAGAATTGTGAACTTTTAAGAGTCTGACT 3121 AGAAATTTGCAACTTATAAAAAAGTTACTTTTAAAAATATAAGTTAGGGCTAGGCACAGTGGCTCATGCCTATAATCTCA 3201 GCACTTTTGGGAGGCCAAGACAGGAGGATCACTTCAGGCCAGGAGTTCAAGATCAACCAACCTGGGTAACATGGCCAGAC 3281 CCCATCTCTATTTATATATATATATATAAAACTTAGAGTTTTTATCTTCCCCTAAAAGAGGCCGTGATATTTGCAGCAGC 3361 CTCAAATTGCTCTTAAGGGGTTTAGGTGTGCAGAAGCTTTCCTTTCCCTACCCAGTAACCATGTGACTACTAACGTGGTA 3441 TATTGATTTATTTTGTTTGCTGTCTGTCTCCCCTGCCCCACTGCTGGAACAGAGGCTCCAAGAAAACAGGGACCTTATTA 3521 TTCATTACTGCATCCCCAGTAATGAAAGTACTTAGAAAATAATTATTGAATGAATGAAATCTAAACTGTGAACCTGAGGG 3601 TGTTTGTGGCAGTGTTTGTTTTACTGAATTGTAGAAGGACATAACCGTGTTTTCAGTGTTTCTATGGAACAAACTTGTAC 3681 ATTTTATTTCACTTGTGTTTTGTCTTAAACCCTACTGCTGGAAACAATTTTATGTAATAAGCAATGGGCCCAAAAGTCTA 3761 GGAGTTTTTTTGTACTTAGTGAATTTGTATGCAACAGAGATGCTGCAGCTGATGCCTTTAAAAGGTATTCATCATGGAAG 3841 AGCTGAGGCCTGTGCTTGGTGTTCCAGAGCCCAGGGTTGAGCATCCTGAAGGAGCCACTGCAGCCGTCACTGTCCCCAGA 3921 GCCTGTGGAGATAGAGCCTGTTTGCTGCTTTTTCTTCCCGCTCTTAAGACATGGCTGGAGCTCAGTCTTCATTGAATGAA 4001 GTTTGCTGTGGTATTGCATAGCCTTGCTTTCTTGAACTAAACTGTTTGCCCTTCACAAGTAGTTCTTCTTTCAGGATTAG 4081 TTCGTTCCAAGGAGGCTCTTCAGTCTCACAGATAAGTAGATCTCTCCTGCTGTCTGGACACATTTCACTCGGAAATTGAA 4161 TACAATTTGTATTCAGGCTGGGAACCTGAACACACACTTGTGTTTTTAAGCTTCCCTTTTTTACAGTGGACAAGGACACA 4241 AATAATAAATAAATCATCCCTAATGCCCAAGAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Disease | 3454.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714644. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | TZM-bl | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM714644 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repA |
Location of target site | ENST00000270139.3 | 3UTR | CUCACUGCAACCUCGCCUCCCGGGUUCAAGCAAUUCUCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000270139.3 | 3UTR | AUCUCGGCUCACUGCAACCUCGCCUCCCGGGUUCAAGCAAUUCUCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
113 hsa-miR-3123 Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT058369 | TBCEL | tubulin folding cofactor E like | ![]() |
![]() |
2 | 4 | ||||||
MIRT059816 | EFNA1 | ephrin A1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT066850 | TMEM19 | transmembrane protein 19 | ![]() |
![]() |
2 | 2 | ||||||
MIRT071503 | CALM1 | calmodulin 1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT073758 | NUBP1 | nucleotide binding protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT074324 | TNRC6A | trinucleotide repeat containing 6A | ![]() |
![]() |
2 | 10 | ||||||
MIRT094805 | LMNB1 | lamin B1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT099173 | MAP3K4 | mitogen-activated protein kinase kinase kinase 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT099545 | ID4 | inhibitor of DNA binding 4, HLH protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT122643 | E2F3 | E2F transcription factor 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT180918 | RPRD2 | regulation of nuclear pre-mRNA domain containing 2 | ![]() |
![]() |
2 | 8 | ||||||
MIRT192844 | BLOC1S6 | biogenesis of lysosomal organelles complex 1 subunit 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT224984 | BAG4 | BCL2 associated athanogene 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT246065 | NRAS | NRAS proto-oncogene, GTPase | ![]() |
![]() |
2 | 2 | ||||||
MIRT357085 | PRRC1 | proline rich coiled-coil 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT378170 | C5ORF51 | chromosome 5 open reading frame 51 | ![]() |
![]() |
2 | 2 | ||||||
MIRT441636 | KDM5A | lysine demethylase 5A | ![]() |
![]() |
2 | 2 | ||||||
MIRT441802 | BCAS1 | breast carcinoma amplified sequence 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT443019 | C21orf91 | chromosome 21 open reading frame 91 | ![]() |
![]() |
2 | 2 | ||||||
MIRT443445 | SERPINB4 | serpin family B member 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT443661 | SERPINB3 | serpin family B member 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT443776 | STS | steroid sulfatase | ![]() |
![]() |
2 | 2 | ||||||
MIRT444663 | TSPAN14 | tetraspanin 14 | ![]() |
![]() |
2 | 2 | ||||||
MIRT444924 | KIAA1522 | KIAA1522 | ![]() |
![]() |
2 | 2 | ||||||
MIRT445378 | FOXO1 | forkhead box O1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT447920 | PAIP2B | poly(A) binding protein interacting protein 2B | ![]() |
![]() |
2 | 2 | ||||||
MIRT449202 | PTPLAD2 | 3-hydroxyacyl-CoA dehydratase 4 | ![]() |
1 | 1 | |||||||
MIRT449713 | TSPYL1 | TSPY like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT450403 | TMEM47 | transmembrane protein 47 | ![]() |
![]() |
2 | 2 | ||||||
MIRT450787 | PAPOLG | poly(A) polymerase gamma | ![]() |
![]() |
2 | 2 | ||||||
MIRT451381 | C19orf43 | telomerase RNA component interacting RNase | ![]() |
![]() |
2 | 2 | ||||||
MIRT452507 | WDR1 | WD repeat domain 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT453264 | PARP11 | poly(ADP-ribose) polymerase family member 11 | ![]() |
![]() |
2 | 2 | ||||||
MIRT454642 | FAM83H | family with sequence similarity 83 member H | ![]() |
![]() |
2 | 2 | ||||||
MIRT455513 | C6orf106 | chromosome 6 open reading frame 106 | ![]() |
![]() |
2 | 2 | ||||||
MIRT456709 | LDB1 | LIM domain binding 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT457231 | AP3D1 | adaptor related protein complex 3 delta 1 subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT459235 | MRPS21 | mitochondrial ribosomal protein S21 | ![]() |
![]() |
2 | 2 | ||||||
MIRT460553 | IFNAR1 | interferon alpha and beta receptor subunit 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT461424 | CTSL2 | cathepsin V | ![]() |
![]() |
2 | 3 | ||||||
MIRT462869 | CYP51A1 | cytochrome P450 family 51 subfamily A member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT467178 | SPTY2D1 | SPT2 chromatin protein domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT469233 | RHOBTB3 | Rho related BTB domain containing 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT474125 | LIPC | lipase C, hepatic type | ![]() |
![]() |
2 | 2 | ||||||
MIRT475509 | HSP90B1 | heat shock protein 90 beta family member 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT478134 | DHX36 | DEAH-box helicase 36 | ![]() |
![]() |
2 | 2 | ||||||
MIRT481326 | ATP5A1 | ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle | ![]() |
![]() |
2 | 2 | ||||||
MIRT482003 | AMOTL2 | angiomotin like 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT482230 | AHCYL2 | adenosylhomocysteinase like 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT483436 | RHOXF2B | Rhox homeobox family member 2B | ![]() |
![]() |
2 | 2 | ||||||
MIRT483824 | ZC3H12B | zinc finger CCCH-type containing 12B | ![]() |
![]() |
2 | 2 | ||||||
MIRT492051 | TNFSF9 | TNF superfamily member 9 | ![]() |
![]() |
2 | 2 | ||||||
MIRT494114 | DLX6 | distal-less homeobox 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT498882 | ZNF12 | zinc finger protein 12 | ![]() |
![]() |
2 | 10 | ||||||
MIRT499674 | NPHP3 | nephrocystin 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT506932 | IGDCC4 | immunoglobulin superfamily DCC subclass member 4 | ![]() |
![]() |
2 | 6 | ||||||
MIRT509461 | ZNF587 | zinc finger protein 587 | ![]() |
![]() |
2 | 6 | ||||||
MIRT510048 | AKR1B10 | aldo-keto reductase family 1 member B10 | ![]() |
![]() |
2 | 4 | ||||||
MIRT514807 | NWD1 | NACHT and WD repeat domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT515217 | CRCP | CGRP receptor component | ![]() |
![]() |
2 | 2 | ||||||
MIRT515486 | INCENP | inner centromere protein | ![]() |
![]() |
2 | 4 | ||||||
MIRT517765 | ZNF366 | zinc finger protein 366 | ![]() |
![]() |
2 | 4 | ||||||
MIRT518216 | TRMT10B | tRNA methyltransferase 10B | ![]() |
![]() |
2 | 2 | ||||||
MIRT519602 | ZNF805 | zinc finger protein 805 | ![]() |
![]() |
2 | 2 | ||||||
MIRT523570 | GGCX | gamma-glutamyl carboxylase | ![]() |
![]() |
2 | 4 | ||||||
MIRT525795 | SOD2 | superoxide dismutase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT533055 | ZBTB37 | zinc finger and BTB domain containing 37 | ![]() |
![]() |
2 | 2 | ||||||
MIRT534218 | SLC37A3 | solute carrier family 37 member 3 | ![]() |
![]() |
2 | 4 | ||||||
MIRT535633 | NR2E1 | nuclear receptor subfamily 2 group E member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT535863 | MRPL17 | mitochondrial ribosomal protein L17 | ![]() |
![]() |
2 | 2 | ||||||
MIRT536344 | LEFTY1 | left-right determination factor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT537923 | DSTYK | dual serine/threonine and tyrosine protein kinase | ![]() |
![]() |
2 | 2 | ||||||
MIRT543114 | SKA2 | spindle and kinetochore associated complex subunit 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT544717 | ZNF529 | zinc finger protein 529 | ![]() |
![]() |
2 | 2 | ||||||
MIRT544847 | BASP1 | brain abundant membrane attached signal protein 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT545536 | ARF3 | ADP ribosylation factor 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT547124 | PHLPP2 | PH domain and leucine rich repeat protein phosphatase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT548070 | GIGYF1 | GRB10 interacting GYF protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT548446 | EIF1AX | eukaryotic translation initiation factor 1A, X-linked | ![]() |
![]() |
2 | 2 | ||||||
MIRT548626 | DAZAP1 | DAZ associated protein 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT550259 | FAM120AOS | family with sequence similarity 120A opposite strand | ![]() |
![]() |
2 | 2 | ||||||
MIRT551940 | AKAP8 | A-kinase anchoring protein 8 | ![]() |
![]() |
2 | 4 | ||||||
MIRT552511 | ZIK1 | zinc finger protein interacting with K protein 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT554015 | SPIRE1 | spire type actin nucleation factor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT556647 | KPNA2 | karyopherin subunit alpha 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT559744 | ACOX1 | acyl-CoA oxidase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT560393 | TMEM254 | transmembrane protein 254 | ![]() |
![]() |
2 | 2 | ||||||
MIRT562234 | HMGB2 | high mobility group box 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT563325 | ORC4 | origin recognition complex subunit 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT563697 | RPS26 | ribosomal protein S26 | ![]() |
![]() |
2 | 2 | ||||||
MIRT565066 | USP25 | ubiquitin specific peptidase 25 | ![]() |
![]() |
2 | 2 | ||||||
MIRT565349 | TMED2 | transmembrane p24 trafficking protein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT565624 | SLC31A1 | solute carrier family 31 member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT566379 | PNISR | PNN interacting serine and arginine rich protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT567575 | FEM1C | fem-1 homolog C | ![]() |
![]() |
2 | 2 | ||||||
MIRT569383 | DDX20 | DEAD-box helicase 20 | ![]() |
![]() |
2 | 2 | ||||||
MIRT570037 | FAM228A | family with sequence similarity 228 member A | ![]() |
![]() |
2 | 2 | ||||||
MIRT573269 | DCAF10 | DDB1 and CUL4 associated factor 10 | ![]() |
![]() |
2 | 2 | ||||||
MIRT573912 | PARP1 | poly(ADP-ribose) polymerase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT620034 | ST6GALNAC3 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT635606 | ZWILCH | zwilch kinetochore protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT644413 | FRMD6 | FERM domain containing 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT652528 | TM9SF4 | transmembrane 9 superfamily member 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT656238 | MFSD6 | major facilitator superfamily domain containing 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT661373 | DYRK4 | dual specificity tyrosine phosphorylation regulated kinase 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT662530 | PNPLA4 | patatin like phospholipase domain containing 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT675551 | MALL | mal, T-cell differentiation protein like | ![]() |
![]() |
2 | 2 | ||||||
MIRT693650 | ACBD7 | acyl-CoA binding domain containing 7 | ![]() |
![]() |
2 | 2 | ||||||
MIRT696348 | SLC35D2 | solute carrier family 35 member D2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT705815 | AKNA | AT-hook transcription factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT707632 | TARDBP | TAR DNA binding protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT717902 | COPS8 | COP9 signalosome subunit 8 | ![]() |
![]() |
2 | 2 | ||||||
MIRT723626 | SOBP | sine oculis binding protein homolog | ![]() |
![]() |
2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|